TherapeuticsMD (TXMD) Share-based Compensation (2011 - 2026)

TherapeuticsMD has reported Share-based Compensation for 16 years, with the latest figure at $2000.0 in Q1 2026.

• For the quarter ending Q1 2026, Share-based Compensation fell 91.3% year-over-year to $2000.0; the trailing twelve-month figure through Mar 2026 stood at $54000.0 (down 69.32% YoY), and the FY2025 full-year result was $75000.0, down 71.59% from the prior year.
• Share-based Compensation for Q1 2026 stood at $2000.0, down from $51000.0 in the prior quarter.
• The five-year high for Share-based Compensation was $4.3 million in Q3 2022, with the low at $1000.0 in Q2 2025.
• Historically, Share-based Compensation has averaged $704437.5 across 5 years, with a median of $113500.0 in 2023.
• The largest YoY upside for Share-based Compensation was 112.5% in 2025 against a maximum downside of 98.96% in 2025.
• TherapeuticsMD's Share-based Compensation stood at $1.1 million in 2022, then tumbled by 89.45% to $116000.0 in 2023, then sank by 79.31% to $24000.0 in 2024, then soared by 112.5% to $51000.0 in 2025, then tumbled by 96.08% to $2000.0 in 2026.
• The last three Share-based Compensation figures came in at $2000.0 (Q1 2026), $51000.0 (Q4 2025), and $1000.0 (Q2 2025), per Business Quant data.